C12N 2750/14131
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2750/14131 (Uses of virus other than therapeutic or vaccine) appears on 2 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 9
- Assignees
- 10
- Inventors
- 18
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 3 |
| 2021 | 0 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2A19 Aug 2025US 12,391,928 B2Research Institute At Nationwide Children's Hospital
- AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies9 Aug 2022US 11,408,899 B2The Children’s Hospital of Philadelphia
- Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a5 Mar 2026US 2026/0062681 A1Research Institute At Nationwide Children's Hospital
- Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies12 Feb 2026US 2026/0043810 A1The Children’s Hospital of Philadelphia
- Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies20 Oct 2022US 2022/0334126 A1The Children’s Hospital of Philadelphia
- Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2a9 Sep 2021US 2021/0277362 A1Research Institute At Nationwide Children's Hospital
- Reagent coated lenses4 Mar 2021US 2021/0059578 A1Inscopix, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.